Erector Spinae Plane (ESP) block in breast surgery
Not Applicable
- Conditions
- Health Condition 1: null- Female patients, aged between 18-70 years of age undergoing any breast surgeryHealth Condition 2: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2018/11/016389
- Lead Sponsor
- AIIMS New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Female patients undergoing elective unilateral breast surgeries with or without axillary clearance.
Aged between 18-65 year of age
ASA (American Society of Anesthesiology) Physical status I and II patients
Exclusion Criteria
Patients refusal to participate in the study
History of coagulation disorders, antiplatelet therapy, anticoagulant therapy.
Morbid obesity with BMI >=35kg/m2
Thoracic vertebral anomalies and severe chest wall deformity
Known allergy to study drugs
Patients with infection at the site of proposed block
Pregnancy
Severe cardiac, renal and hepatic conditions
Thyrotoxicosis
Mental retardation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the duration of analgesia produced by three regional anaesthetic techniques (ESP, TPVB and SAP blocks) in patients undergoing any breast surgery under general anaesthesia. <br/ ><br>Timepoint: immediate post operative period (0 hour) <br/ ><br> <br/ ><br>Then at 1st, 2nd, 4th, 6th, 12th, 18th and 24th hour of surgery
- Secondary Outcome Measures
Name Time Method Secondary Objectives <br/ ><br>1.To compare the total rescue opioid or opioid equivalent drugs required in the first 24 hours after surgery. <br/ ><br>2.To compare the complications associated with the three regional anaesthetic techniques. <br/ ><br> <br/ ><br>Timepoint: At 0, 1, 2, 3,6, 12 and 24 hours